Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Inj eflapegrastim-xnst 0.1mg (CPT 9114) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 28, 2026 , from http://ppman.hank.ai/transparency/procedure/9114/by-state?code_type=CPT
“Inj eflapegrastim-xnst 0.1mg (CPT 9114) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/9114/by-state?code_type=CPT. Accessed
June 28, 2026 .
“Inj eflapegrastim-xnst 0.1mg (CPT 9114) by State,” HANK Price Transparency ,
accessed June 28, 2026 ,
http://ppman.hank.ai/transparency/procedure/9114/by-state?code_type=CPT.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CPT · across United States
9114 — Inj Eflapegrastim-xnst 0.1mg
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$33
National median
$22 – $2,827
IQR (p25 – p75)
19
hospitals filing
7
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 9114 (CPT), with interquartile range
State Median p25 p75
SD $173,283 $111,017 $181,859
MN $81,523 $58,165 $104,881
IL $712 $371 $1,607
TX $30 $23 $36,677
CA $24 $23 $2,827
NV $22 $22 $23
KY $19 $19 $19